TGF-β maintains dormancy of prostatic stem cells in the proximal region of ducts

被引:100
作者
Salm, SN
Burger, PE
Coetzee, S
Goto, K
Moscatelli, D
Wilson, EL [1 ]
机构
[1] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Urol, New York, NY 10016 USA
[3] NYU, Sch Med, Kaplan Canc Ctr, New York, NY 10016 USA
[4] Borough Manhattan Community Coll, Dept Sci, New York, NY 10007 USA
[5] Univ Cape Town, Sch Med, Div Immunol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa
[6] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 8128582, Japan
关键词
D O I
10.1083/jcb.200412015
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have previously shown that prostatic stem cells are located in the proximal region of mouse prostatic ducts. Here, we show that this region responds differently to transforming growth factor (TGF)-beta than the distal ductal region and that under physiological conditions androgens and TGF-beta are crucial overall regulators of prostatic tissue homeostasis. This conclusion is supported by the observations showing that high levels of TGF-beta signaling are present in the quiescent proximal region of ducts in an androgen-replete animal and that cells in this region overexpress Bcl-2, which protects them from apoptosis. Moreover, androgen ablation W reverses the proximal-distal TGF-beta signaling gradient, leading to an increase in TGF-beta signaling in the unprotected distal region (low Bcl-2 expression). This reversal of TGF-beta-mediated signaling accompanies apoptosis of cells in the distal region and gland involution after androgen withdrawal. A physiological TGF-beta signaling gradient ( high proximally and low distally) and its functional correlates are restored after androgen replenishment. In addition to highlighting the regulatory role of androgens and TGF-beta, these findings may have important implications for the deregulation of the stem cell compartment in the etiology of proliferative prostatic diseases.
引用
收藏
页码:81 / 90
页数:10
相关论文
共 51 条
[1]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[3]   Tissue repair and stem cell renewal in carcinogenesis [J].
Beachy, PA ;
Karhadkar, SS ;
Berman, DM .
NATURE, 2004, 432 (7015) :324-331
[4]   bcl-2 Antagonizes the combined apoptotic effect of transforming growth factor-β and dihydrotestosterone in prostate cancer cells [J].
Bruckheimer, EM ;
Kyprianou, N .
PROSTATE, 2002, 53 (02) :133-142
[5]  
CASHMAN JD, 1992, LEUKEMIA, V6, P886
[6]  
Cunha G R, 1987, Prog Clin Biol Res, V239, P251
[7]  
Danielpour D, 1999, J CELL SCI, V112, P169
[8]   Mechanisms of muscle stem cell expansion with cytokines [J].
Deasy, BM ;
Qu-Peterson, Z ;
Greenberger, JS ;
Huard, J .
STEM CELLS, 2002, 20 (01) :50-60
[9]   The role of apoptosis in the regulation of hematopoietic stem cells:: Overexpression of BCL-2 increases both their number and repopulation potential [J].
Domen, J ;
Cheshier, SH ;
Weissman, IL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (02) :253-263
[10]   Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other [J].
Domen, J ;
Weissman, IL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (12) :1707-1718